(Circulation. 1999;99:2537-2542.)
© 1999 American Heart Association, Inc.
Clinical Investigation and Reports |
Increased Sympathetic Nerve Activity in Renovascular Hypertension
From the Departments of Clinical Physiology (M.J., G.L., P.F.), Clinical Neurophysiology (M.E.), Cardiology (B.R.), and Nephrology (H.H.), Göteborg University, Sahlgrenska University Hospital, Göteborg, Sweden, and National Institutes of Neurological Disorders and Stroke (G.E.), Bethesda, Md.
Correspondence to Peter Friberg, MD, PhD, Department of Clinical Physiology, Sahlgrenska University Hospital, SE 413 45 Göteborg, Sweden. E-mail fribergp{at}mednet.gu.se
Background—Increased sympathetic nerve activity may contribute to the progression of renovascular hypertension. Because previous results have been inconclusive, we investigated whether renovascular hypertensives show increased total and regional sympathetic nerve activity.
Methods and Results—Sixty-five patients underwent renal angiography and measurements of plasma renin activity and angiotensin II in conjunction with estimation of sympathetic nerve activity by means of radiotracer dilution and intraneural recordings of muscle sympathetic nerve activity (MSNA). Age-matched healthy subjects (n=15) were examined for comparison. Total body norepinephrine (NE) spillover, an index of overall sympathetic nerve activity, was increased by 100% and MSNA by 60% in the hypertensive patients compared with healthy subjects (P<0.01 for both). A subgroup of 24 patients with well-defined renovascular hypertension (cured or improved hypertension after renal angioplasty) showed similar increases in total body NE spillover compared with the group at large. Patients with arterial plasma renin activity and angiotensin II levels above median had higher values for total body NE spillover than patients below median (P<0.01).
Conclusions—This study unequivocally demonstrates elevated sympathetic nerve activity in patients with renovascular hypertension. The adrenergic overactivity may contribute to the blood pressure elevation and perhaps also to the high cardiovascular mortality in renovascular hypertension.
Key Words: hypertension • nervous system, sympathetic • renin
This article has been cited by other articles:
 |
|
 |
|
  G. J Dubel and T. P Murphy The role of percutaneous revascularization for renal artery stenosis Vascular Medicine, May 1, 2008; 13(2): 141 - 156. [Abstract] [PDF]
|
|
|
|
 |
|
 F. D. McBryde, S.-J. Guild, C. J. Barrett, J. W. Osborn, and S. C. Malpas Cardiovascular Control: Angiotensin II-based hypertension and the sympathetic nervous system: the role of dose and increased dietary salt in rabbits Exp Physiol, September 1, 2007; 92(5): 831 - 840. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. G. Evans, S. L. Burke, G. W. Lambert, and G. A. Head Renal responses to acute reflex activation of renal sympathetic nerve activity and renal denervation in secondary hypertension Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R1247 - R1256. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Davern and G. A. Head Fos-Related Antigen Immunoreactivity After Acute and Chronic Angiotensin II-Induced Hypertension in the Rabbit Brain Hypertension, May 1, 2007; 49(5): 1170 - 1177. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Burke, G. A. Head, G. W. Lambert, and R. G. Evans Renal Sympathetic Neuroeffector Function in Renovascular and Angiotensin II-Dependent Hypertension in Rabbits Hypertension, April 1, 2007; 49(4): 932 - 938. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Cooper and T. P. Murphy The Case for Renal Artery Stenting for Treatment of Renal Artery Stenosis Circulation, January 16, 2007; 115(2): 263 - 270. [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Kennedy, M. W. Burket, S. A. Khuder, J. I. Shapiro, R. V. Topp, and C. J. Cooper Quality of life improves after renal artery stenting. Biol Res Nurs, October 1, 2006; 8(2): 129 - 137. [Abstract] [PDF]
|
|
|
|
 |
|
 R. de Silva, N. P. Nikitin, S. Bhandari, A. Nicholson, A. L. Clark, and J. G.F. Cleland Atherosclerotic renovascular disease in chronic heart failure: should we intervene? Eur. Heart J., August 2, 2005; 26(16): 1596 - 1605. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Vonend, A. Okonek, J. Stegbauer, S. Habbel, I. Quack, and L. C. Rump Renovascular effects of sympathetic cotransmitters ATP and NPY are age-dependent in spontaneoulsy hypertensive rats Cardiovasc Res, May 1, 2005; 66(2): 345 - 352. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. E. Lohmeier, D. A. Hildebrandt, S. Warren, P. J. May, and J. T. Cunningham Recent insights into the interactions between the baroreflex and the kidneys in hypertension Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2005; 288(4): R828 - R836. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Ran, T. Hirano, and M. Adachi Chronic ANG II infusion increases plasma triglyceride level by stimulating hepatic triglyceride production in rats Am J Physiol Endocrinol Metab, November 1, 2004; 287(5): E955 - E961. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. A. Head and S. L. Burke Sympathetic Responses to Stress and Rilmenidine in 2K1C Rabbits: Evidence of Enhanced Nonvascular Effector Mechanism Hypertension, March 1, 2004; 43(3): 636 - 642. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Grisk and R. Rettig Interactions between the sympathetic nervous system and the kidneys in arterial hypertension Cardiovasc Res, February 1, 2004; 61(2): 238 - 246. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Y.H. Chan, L.-L. Wang, Y.-M. Chao, and S. H.H. Chan Downregulation of Basal iNOS at the Rostral Ventrolateral Medulla Is Innate in SHR Hypertension, March 1, 2003; 41(3): 563 - 570. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Dendorfer, A. Thornagel, W. Raasch, O. Grisk, K. Tempel, and P. Dominiak Angiotensin II Induces Catecholamine Release by Direct Ganglionic Excitation Hypertension, September 1, 2002; 40(3): 348 - 354. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kagiyama, A. Varela, M. I. Phillips, and S. M. Galli Antisense Inhibition of Brain Renin-Angiotensin System Decreased Blood Pressure in Chronic 2-Kidney, 1 Clip Hypertensive Rats Hypertension, February 1, 2001; 37(2): 371 - 375. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. C. Rump, K. Amann, S. Orth, and E. Ritz Sympathetic overactivity in renal disease: a window to understand progression and cardiovascular complications of uraemia? Nephrol. Dial. Transplant., November 1, 2000; 15(11): 1735 - 1738. [Full Text] [PDF]
|
|
|
|
|
|
O. Grisk, B. A. J. Frey, A. Uber, and R. Rettig Sympathetic activity in early renal posttransplantation hypertension in rats Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2000; 279(5): R1737 - R1744. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Johansson, M. Elam, B. Rundqvist, G. Eisenhofer, H. Herlitz, G. Jensen, and P. Friberg Differentiated Response of the Sympathetic Nervous System to Angiotensin-Converting Enzyme Inhibition in Hypertension Hypertension, October 1, 2000; 36(4): 543 - 548. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. N. Muscara, W. McKnight, F. Lovren, C. R. Triggle, G. Cirino, and J. L. Wallace Antihypertensive properties of a nitric oxide-releasing naproxen derivative in two-kidney, one-clip rats Am J Physiol Heart Circ Physiol, August 1, 2000; 279(2): H528 - H535. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. D. Frohlich Research Means "Look Back" Hypertension, March 1, 2000; 35(3): 693 - 693. [Full Text] [PDF]
|
|
|
|
|
|
L. Moser, J. Faulhaber, R. J. Wiesner, and H. Ehmke Predominant activation of endothelin-dependent cardiac hypertrophy by norepinephrine in rat left ventricle Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2002; 282(5): R1389 - R1394. [Abstract] [Full Text] [PDF]
|
|